These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33371158)

  • 1. The comparison of the effectiveness and safety of drospirone ethinyl estradiol and ethinyl estradiol cyproterone in the treatment of polycystic ovarian syndrome: A protocol for systematic review and meta-analysis.
    Liu Z; Song Y; Xu Y; Wang J; Hu H; Weng Y
    Medicine (Baltimore); 2020 Dec; 99(51):e23811. PubMed ID: 33371158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and safety of traditional Chinese medicine Jinfeng pill in adjuvant treatment of infertility with polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
    Zhu P; Guan JZ; Hai QC; Jin J; Shi L; Hua L
    Medicine (Baltimore); 2022 Jan; 101(4):e28676. PubMed ID: 35089214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of moxibustion in the treatment of infertility with polycystic ovary syndrome: A protocol of systematic review and meta-analysis.
    Ye W; Deng G; Yin L; Ye J
    Medicine (Baltimore); 2021 Mar; 100(11):e24529. PubMed ID: 33725936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen L; Vauhkonen I; Koivunen R; Ruokonen A; Martikainen H; Tapanainen JS
    J Clin Endocrinol Metab; 2003 Jan; 88(1):148-56. PubMed ID: 12519844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chinese herbal medicine on treating obese women with polycystic ovary syndrome: A systematic review and meta-analysis protocol.
    Ding N; Yue R; Wang L; Yang H
    Medicine (Baltimore); 2020 Dec; 99(49):e22982. PubMed ID: 33285679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome.
    Fruzzetti F; Perini D; Lazzarini V; Parrini D; Gambacciani M; Genazzani AR
    Fertil Steril; 2010 Oct; 94(5):1793-8. PubMed ID: 19931080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin action and insulin secretion in polycystic ovary syndrome treated with ethinyl oestradiol/cyproterone acetate.
    Armstrong VL; Wiggam MI; Ennis CN; Sheridan B; Traub AI; Atkinson AB; Bell PM
    QJM; 2001 Jan; 94(1):31-7. PubMed ID: 11161134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative effectiveness of 55 interventions in obese patients with polycystic ovary syndrome: A network meta-analysis of 101 randomized trials.
    Abdel-Maboud M; Menshawy A; Hasabo EA; Abdelraoof MI; Alshandidy M; Eid M; Menshawy E; Outani O; Menshawy A
    PLoS One; 2021; 16(7):e0254412. PubMed ID: 34280195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin.
    Cakiroglu Y; Vural B; Isgoren S
    Arch Gynecol Obstet; 2013 Jul; 288(1):213-20. PubMed ID: 23377194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Efficacy and metabolic safety of long-term treatment with ethinyl oestradiol/cyproterone and desogestrel/ethinyl oestradiol tablets in women with polycystic ovary syndrome].
    Zhang J; Su M; Xu L; Yang Z; Yin W; Nie Y; Qiao X; Cheng R; Ma Y
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):917-922. PubMed ID: 30187872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of two oral contraceptive forms containing cyproterone acetate and drospirenone in the treatment of patients with polycystic ovary syndrome: a randomized clinical trial.
    Kahraman K; Sükür YE; Atabekoğlu CS; Ateş C; Taşkın S; Cetinkaya SE; Tolunay HE; Ozmen B; Sönmezer M; Berker B
    Arch Gynecol Obstet; 2014 Aug; 290(2):321-8. PubMed ID: 24676694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination.
    Aydin K; Cinar N; Aksoy DY; Bozdag G; Yildiz BO
    Contraception; 2013 Mar; 87(3):358-62. PubMed ID: 22898361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate.
    Markantes G; Saltamavros AD; Vervita V; Armeni AK; Karela A; Adonakis G; Decavalas G; Georgopoulos NA
    Gynecol Endocrinol; 2011 Dec; 27(12):971-7. PubMed ID: 21501001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of long-term administration of an oral contraceptive containing ethinylestradiol and cyproterone acetate on lipid metabolism in women with polycystic ovary syndrome.
    Falsetti L; Pasinetti E
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):56-60. PubMed ID: 7856434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Koivunen RM; Ruokonen A; Martikainen HK; Tapanainen JS
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3161-8. PubMed ID: 10999803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
    Karakurt F; Carlioglu A; Kaygusuz I; Gumus II; Uz B; Akdeniz D
    Arch Gynecol Obstet; 2014 Jan; 289(1):135-40. PubMed ID: 23880889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inositol and alpha lipoic acid combination for polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
    Lei W; Gao Y; Hu S; Liu D; Chen Q
    Medicine (Baltimore); 2020 Jul; 99(30):e20696. PubMed ID: 32791663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome.
    Cinar N; Harmanci A; Bayraktar M; Yildiz BO
    Clin Endocrinol (Oxf); 2013 Mar; 78(3):379-84. PubMed ID: 22509734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cyproterone acetate/ethinyl estradiol combination on periodontal status and high-sensitivity C-reactive protein levels in women with polycystic ovary syndrome: a cross-sectional study.
    Singhal R; Tewari S; Sharma R; Singhal S; Tanwar N; Sangwan A
    Quintessence Int; 2024 Apr; 55(4):274-285. PubMed ID: 38391191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.